Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98


The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression.

Aigner K, Descovich L, Mikula M, Sultan A, Dampier B, Bonné S, van Roy F, Mikulits W, Schreiber M, Brabletz T, Sommergruber W, Schweifer N, Wernitznig A, Beug H, Foisner R, Eger A.

FEBS Lett. 2007 Apr 17;581(8):1617-24. Epub 2007 Mar 21.


The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, Sommergruber W, Schweifer N, Wernitznig A, Beug H, Foisner R, Eger A.

Oncogene. 2007 Oct 25;26(49):6979-88. Epub 2007 May 7.


Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer.

Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, Furihata M.

FEBS Lett. 2009 Jan 22;583(2):430-6. doi: 10.1016/j.febslet.2008.12.042. Epub 2008 Dec 29.


δEF1 associates with DNMT1 and maintains DNA methylation of the E-cadherin promoter in breast cancer cells.

Fukagawa A, Ishii H, Miyazawa K, Saitoh M.

Cancer Med. 2015 Jan;4(1):125-35. doi: 10.1002/cam4.347. Epub 2014 Oct 15.


A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, Brabletz T.

EMBO Rep. 2008 Jun;9(6):582-9. doi: 10.1038/embor.2008.74. Epub 2008 May 16.


Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.

Aghdassi A, Sendler M, Guenther A, Mayerle J, Behn CO, Heidecke CD, Friess H, Büchler M, Evert M, Lerch MM, Weiss FU.

Gut. 2012 Mar;61(3):439-48. doi: 10.1136/gutjnl-2011-300060. Epub 2011 Dec 5.


GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.

Perrot CY, Gilbert C, Marsaud V, Postigo A, Javelaud D, Mauviel A.

Pigment Cell Melanoma Res. 2013 Nov;26(6):861-73. doi: 10.1111/pcmr.12149. Epub 2013 Aug 12.


Zeb1 regulates E-cadherin and Epcam (epithelial cell adhesion molecule) expression to control cell behavior in early zebrafish development.

Vannier C, Mock K, Brabletz T, Driever W.

J Biol Chem. 2013 Jun 28;288(26):18643-59. doi: 10.1074/jbc.M113.467787. Epub 2013 May 10.


Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.

Wels C, Joshi S, Koefinger P, Bergler H, Schaider H.

J Invest Dermatol. 2011 Sep;131(9):1877-85. doi: 10.1038/jid.2011.142. Epub 2011 May 19.


The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Park SM, Gaur AB, Lengyel E, Peter ME.

Genes Dev. 2008 Apr 1;22(7):894-907. doi: 10.1101/gad.1640608. Erratum in: Genes Dev. 2009 Jun 1;23(11):1378.


ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.

Sánchez-Tilló E, Lázaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, Engel P, Postigo A.

Oncogene. 2010 Jun 17;29(24):3490-500. doi: 10.1038/onc.2010.102. Epub 2010 Apr 26.


Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.

Huang W, Zhang Y, Varambally S, Chinnaiyan AM, Banerjee M, Merajver SD, Kleer CG.

Am J Pathol. 2008 Apr;172(4):893-904. doi: 10.2353/ajpath.2008.070899. Epub 2008 Mar 5.


MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.

Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, Gregory PA, Khew-Goodall Y.

Oncogene. 2014 Jul 31;33(31):4077-88. doi: 10.1038/onc.2013.370. Epub 2013 Sep 16.


ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor.

Lacher MD, Shiina M, Chang P, Keller D, Tiirikainen MI, Korn WM.

Mol Cancer. 2011 Jul 27;10:91. doi: 10.1186/1476-4598-10-91.


Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.

Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G.

Oncogene. 2014 Mar 6;33(10):1325-35. doi: 10.1038/onc.2013.53. Epub 2013 Mar 11.


Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.

Bakiri L, Macho-Maschler S, Custic I, Niemiec J, Guío-Carrión A, Hasenfuss SC, Eger A, Müller M, Beug H, Wagner EF.

Cell Death Differ. 2015 Feb;22(2):336-50. doi: 10.1038/cdd.2014.157. Epub 2014 Oct 10.


Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.

Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY.

J Biol Chem. 2012 Feb 17;287(8):5819-32. doi: 10.1074/jbc.M111.295964. Epub 2011 Dec 28.


DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, Berx G, Cano A, Beug H, Foisner R.

Oncogene. 2005 Mar 31;24(14):2375-85.


The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.

Huang Q, Miller MR, Schappet J, Henry MD.

Cancer Biol Ther. 2015;16(1):125-36. doi: 10.4161/15384047.2014.987078.

Supplemental Content

Support Center